drugset / Trial / NCT00812344

Effect of Ketoconazole on Biliary Excretion of AZD0837

NCT00812344

Phase 1 Completed 20 enrolled AstraZeneca
RandomizedCrossoverOpen-label

Summary

This is an explorative study and the scientific question to be investigated is if the biliary excretion of AZD0837 and its metabolites AR-H069927XX and AR-H067637XX are affected by co-administration with ketoconazole

Timeline

Start
2008-12
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ATECEGATRAN METOXIL Small molecule Oral
Comparator Ketoconazole Small molecule Oral

Indications

No indication recorded.